COCH predicts survival and adjuvant TACE response in patients with HCC

The aim of the present study was to measure the expression of Cochlin (COCH) and analyze its association with survival, recurrence and the benefits from adjuvant transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) following hepatectomy. Patients with high COCH expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen, Ding, Zhi-Wen, Zheng, Cheng-Gang, Wang, Siyuan, Li, Zhi-Heng, Zhang, Zi-Mu, Pan, Jian, Wang, Jian, Yang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905559/
https://www.ncbi.nlm.nih.gov/pubmed/33732351
http://dx.doi.org/10.3892/ol.2021.12536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905559/
https://www.ncbi.nlm.nih.gov/pubmed/33732351
http://dx.doi.org/10.3892/ol.2021.12536

Ejemplares similares